What to Know About Polycythemia Vera and Treatme... - MPN Voice

MPN Voice

10,608 members14,669 posts

What to Know About Polycythemia Vera and Treatment Options

Manouche profile image
1 Reply

« For those that have not had a chance to use interferons, this is a little different experience than those that just used interferon in the distant past. I’m mindful. I interacted with many oncologists that they have bad memories of using high-dose interferon for chronic myeloid leukemia or even for solid tumors, really high doses lots of toxicity. This is something completely different. This is very low-dose, very long acting. There can be side effects. You need to monitor for liver function, test depression, but it’s a dramatically different story. It can really have an impact »

onclive.com/view/what-to-kn...

Written by
Manouche profile image
Manouche
To view profiles and participate in discussions please or .
Read more about...
1 Reply
hunter5582 profile image
hunter5582

I would give sa big AMEN to that! The PEGyated forms of interferon are a completely different story than the old forms. Effective and much easier to tolerate. It is too bad that so many docs do not understand this. Going on PEG-IFN is he best treatment decision I ever made. I know that not everyone responds as well, but many do. Now that Besremi is becoming more available, perhaps even more will be able to benefit.

You may also like...

Effective Management of Polycythemia Vera With Ropeginterferon Alfa-2b Treatment

with PV at this dosing regimen of a higher starting dose and simpler intra-patient dose titration...

diagnosed with Polycythemia Vera

me on the interferon alpha injections yesterday at the hospital but said it's a very low dose 45...

Increased Besremi Dose to Be Studied for Polycythemia Vera Treatment

https://www.curetoday.com/view/increased-besremi-dose-to-be-studied-for-polycythemia-vera-treatment...

Ropeginterferon Alfa-2b listed as Preferred Treatment in Polycythemia Vera

treatment option for patients with high- and low-risk polycythemia vera, irrespective of treatment...

Cost–effectiveness of ropeginterferon alfa-2b-njft for the treatment of polycythemia vera